Three-Year Follow-Up of First Human Use of Cyanoacrylate Adhesive for Treatment of Saphenous Vein Incompetence.

Severity score improvement was better in overweight and obese patients (P 1⁄4 .019). There was no difference in satisfaction across groups. More obese patients than normal-weight patients had recanalization of treated veins at 5 years (60% vs 29%; P < .0005, c trend). They were also more likely to have required re-treatment by 5 years (28% vs 7%; P 1⁄4 .026). Conclusions: Despite more severe venous disease at baseline, overweight and obese patients had greater symptomatic improvement after UGFS than normal-weight patients did. Although they were more likely to have recanalization and recurrence, their long-term satisfaction remainedhigh.